Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRSS33 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | ERGIC1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | CD83 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | USF3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | TTPAL | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | CHMP4A | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | PET100 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | CCDC96 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | MSANTD1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | COIL | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |